Your browser doesn't support javascript.
loading
Clinical response to sodium glucose co-transporter 2 inhibitor ipragliflozin in a patient with metastatic renal cell carcinoma.
Izumi, Keita; Iimura, Yasumasa; Hiruma, Kiyoshi; Touma, Tsuguhiro; Tsukamoto, Tetsuro.
Affiliation
  • Izumi K; Department of Urology Showa General Hospital Kodairashi, Tokyo Japan.
  • Iimura Y; Department of Urology Showa General Hospital Kodairashi, Tokyo Japan.
  • Hiruma K; Hiruma Clinic Kodairashi, Tokyo Japan.
  • Touma T; Department of Urology Showa General Hospital Kodairashi, Tokyo Japan.
  • Tsukamoto T; Department of Urology Showa General Hospital Kodairashi, Tokyo Japan.
IJU Case Rep ; 2(5): 269-271, 2019 Sep.
Article in En | MEDLINE | ID: mdl-32743434
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IJU Case Rep Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: IJU Case Rep Year: 2019 Document type: Article